相关实验视频
Updated: Jan 12, 2026

06:24
Minimal Erythema Dose MED Testing
Published on: May 28, 2013
42.7K
米诺环素诱导的延迟皮肤特征与对多西环素的耐受性
María Nerea Otero-Fernández1,2, Francisco Javier Muñoz-Bellido1,2,3,4, Elena Laffond-Yges1,2,3,4
1Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.
The Journal of dermatology
|November 7, 2025
概括
米诺环素可以引起罕见的,延迟的症状皮肤表征,皮肤反应. 多西环林似乎是一个安全的替代品,在这个案例研究中没有显示交叉反应.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 米诺环素是一种四环环素抗生素,经常用于治疗炎症性皮肤疾病,如和粉红.
- 虽然通常是安全的,但米诺环素可以诱导过敏反应,包括罕见的不良反应.
- 症状性皮肤表征症是一种慢性诱导性疹,通常用抗组胺药物治疗.
研究的目的:
- 报告一种罕见的口服米诺环素诱导的延迟发作的症状性皮肤表皮病.
- 调查因果关系和与多西环林的潜在交叉反应.
- 突出长期药物再试验对罕见药物不良反应的诊断重要性.
主要方法:
- 一名20岁的男性患者在开始治疗时服用米诺环林后出现了症状.
- 进行了口服米诺环素挑战测试,治疗剂量后9天后症状复发.
- 用多西环林进行了刺,皮内和口服挑战试验,以评估交叉反应性.
主要成果:
- 患者表现出性,线性小麦状病变,与症状性皮肤学相一致.
- 通过口服再试验的积极结果,米诺环素被确定为致病因子.
- 多西环素挑战测试呈阴性,表明没有交叉反应性,并建议其安全性作为替代方案.
结论:
- 米诺环素可能会导致罕见的,晚发症的症状性皮肤表征症,需要临床医生提高认识.
- 长时间的药物再试验对于诊断延迟过敏反应至关重要.
- 多西环素可以为经历米诺环素诱导皮肤表征症的患者提供安全有效的替代品.
相关概念视频
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Cholinergic Antagonists: Pharmacokinetics
889
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
889
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
225
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
225
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
387
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
387

